Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial (Q43893957)
Jump to navigation
Jump to search
scientific article published in January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial |
scientific article published in January 2012 |
Statements
1 reference
Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial (English)
1 reference
Jerzy Windyga
1 reference
Erich V de Paula
1 reference
Kaan Kavakli
1 reference
Johnny Mahlangu
1 reference
Yasmin Ayob
1 reference
Steven R Lentz
1 reference
Massimo Morfini
1 reference
László Nemes
1 reference
Silva Z Šalek
1 reference
Midori Shima
1 reference
Silke Ehrenforth
1 reference
Ampaiwan Chuansumrit
1 reference
1804 (adept(TM)1) Investigators
1 reference
1 January 2012
1 reference
1 reference
10
1 reference
1
1 reference
81-89
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference